Investors on Wall Street can add another layer of uncertainty to a market already unnerved by last month's sell-off, stalled fiscal stimulus and President Donald Trump's COVID-19 diagnosis, which weighed on stocks on Friday.
Twitter Chief Executive Jack Dorsey has agreed to testify before the Senate Commerce Committee on Oct. 28, the company said Friday.
The U.S. unemployment rate fell to 7.9per cent in September, from 8.4per cent in August, a big drop that in normal times would be welcome news for a presidential incumbent seeking reelection in just over a month.
Electric vehicle maker Polestar, owned by Volvo Cars and its parent China's Geely, is recalling all new Polestar 2 cars due to a software glitch, business daily Dagens Industri (DI) said on Friday.
California's health secretary on Friday agreed to hear more input from theme park operators before issuing reopening guidelines, a step that further delays Walt Disney Co's plans to welcome visitors back to Disneyland.
The U.S. Justice Department on Friday said it was appealing a judge's decision to block the government from barring Apple Inc and Alphabet Inc's Google from offering Chinese-owned messaging app WeChat for download in U.S. app stores.
Global banks and investors said they were stepping up their preparations for a victory by Democratic presidential candidate Joe Biden after his rival Republican President Donald Trump revealed he had tested positive for COVID-19 early on Friday.
Home rental company Airbnb Inc is aiming to raise around US$3 billion in its upcoming initial public offering (IPO), people familiar with the matter said on Friday, taking advantage of the unexpectedly sharp recovery in its business after the COVID-19 pandemic roiled the travel industry.
A federal appeals court on Friday reinstated a 2017 jury verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than US$235 million for infringing a patent for its blood pressure drug Coreg.
Google's bid to win EU approval for its US$2.1 billion purchase of Fitbit faces headwinds as rivals and customers argue concessions to EU antitrust regulators do not go far enough, two people familiar with the matter said on Friday.
